サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/11/16 | 1,203 | 1,221 | 1,182 | 1,221 | +23 | +1.9% | 227,200 |
| 2021/11/15 | 1,177 | 1,203 | 1,165 | 1,198 | +13 | +1.1% | 257,000 |
| 2021/11/12 | 1,142 | 1,191 | 1,141 | 1,185 | +29 | +2.5% | 244,500 |
| 2021/11/11 | 1,174 | 1,179 | 1,152 | 1,156 | -33 | -2.8% | 230,100 |
| 2021/11/10 | 1,177 | 1,205 | 1,168 | 1,189 | +15 | +1.3% | 208,000 |
| 2021/11/09 | 1,179 | 1,191 | 1,166 | 1,174 | -7 | -0.6% | 150,400 |
| 2021/11/08 | 1,224 | 1,224 | 1,175 | 1,181 | -44 | -3.6% | 257,900 |
| 2021/11/05 | 1,205 | 1,228 | 1,196 | 1,225 | +27 | +2.3% | 202,000 |
| 2021/11/04 | 1,245 | 1,246 | 1,193 | 1,198 | -29 | -2.4% | 260,600 |
| 2021/11/02 | 1,222 | 1,244 | 1,221 | 1,227 | +29 | +2.4% | 207,100 |
| 2021/11/01 | 1,224 | 1,224 | 1,183 | 1,198 | -3 | -0.2% | 173,500 |
| 2021/10/29 | 1,241 | 1,245 | 1,200 | 1,201 | -32 | -2.6% | 190,900 |
| 2021/10/28 | 1,251 | 1,256 | 1,233 | 1,233 | -28 | -2.2% | 150,300 |
| 2021/10/27 | 1,228 | 1,264 | 1,228 | 1,261 | +37 | +3% | 341,400 |
| 2021/10/26 | 1,177 | 1,228 | 1,177 | 1,224 | +50 | +4.3% | 240,900 |
| 2021/10/25 | 1,191 | 1,191 | 1,160 | 1,174 | -32 | -2.7% | 296,800 |
| 2021/10/22 | 1,198 | 1,224 | 1,188 | 1,206 | -14 | -1.1% | 257,400 |
| 2021/10/21 | 1,279 | 1,279 | 1,205 | 1,220 | -63 | -4.9% | 345,500 |
| 2021/10/20 | 1,268 | 1,286 | 1,251 | 1,283 | +25 | +2% | 267,300 |
| 2021/10/19 | 1,242 | 1,265 | 1,237 | 1,258 | +16 | +1.3% | 172,900 |
| 2021/10/18 | 1,232 | 1,251 | 1,216 | 1,242 | +2 | +0.2% | 259,400 |
| 2021/10/15 | 1,190 | 1,240 | 1,175 | 1,240 | +79 | +6.8% | 474,800 |
| 2021/10/14 | 1,133 | 1,169 | 1,133 | 1,161 | +33 | +2.9% | 256,000 |
| 2021/10/13 | 1,124 | 1,140 | 1,119 | 1,128 | -2 | -0.2% | 165,400 |
| 2021/10/12 | 1,142 | 1,153 | 1,124 | 1,130 | -24 | -2.1% | 202,400 |
| 2021/10/11 | 1,149 | 1,160 | 1,118 | 1,154 | +6 | +0.5% | 295,300 |
| 2021/10/08 | 1,116 | 1,149 | 1,110 | 1,148 | +38 | +3.4% | 298,700 |
| 2021/10/07 | 1,092 | 1,124 | 1,087 | 1,110 | +14 | +1.3% | 296,900 |
| 2021/10/06 | 1,130 | 1,146 | 1,092 | 1,096 | -30 | -2.7% | 440,700 |
| 2021/10/05 | 1,142 | 1,147 | 1,103 | 1,126 | -37 | -3.2% | 441,700 |
| 2021/10/04 | 1,190 | 1,204 | 1,151 | 1,163 | -26 | -2.2% | 334,200 |
| 2021/10/01 | 1,192 | 1,200 | 1,176 | 1,189 | -9 | -0.8% | 319,500 |
| 2021/09/30 | 1,209 | 1,222 | 1,195 | 1,198 | -10 | -0.8% | 174,400 |
| 2021/09/29 | 1,200 | 1,216 | 1,170 | 1,208 | -3 | -0.2% | 401,200 |
| 2021/09/28 | 1,227 | 1,231 | 1,202 | 1,211 | -16 | -1.3% | 300,000 |
| 2021/09/27 | 1,250 | 1,256 | 1,225 | 1,227 | -25 | -2% | 173,800 |
| 2021/09/24 | 1,240 | 1,262 | 1,231 | 1,252 | +40 | +3.3% | 351,900 |
| 2021/09/22 | 1,206 | 1,245 | 1,202 | 1,212 | -9 | -0.7% | 352,300 |
| 2021/09/21 | 1,215 | 1,231 | 1,202 | 1,221 | -38 | -3% | 376,000 |
| 2021/09/17 | 1,263 | 1,270 | 1,213 | 1,259 | +8 | +0.6% | 600,000 |
| 2021/09/16 | 1,292 | 1,302 | 1,236 | 1,251 | -52 | -4% | 707,900 |
| 2021/09/15 | 1,255 | 1,350 | 1,216 | 1,303 | +60 | +4.8% | 1,590,400 |
| 2021/09/14 | 1,249 | 1,255 | 1,233 | 1,243 | -5 | -0.4% | 292,400 |
| 2021/09/13 | 1,238 | 1,256 | 1,221 | 1,248 | ±0 | ±0% | 296,600 |
| 2021/09/10 | 1,234 | 1,252 | 1,215 | 1,248 | +28 | +2.3% | 333,400 |
| 2021/09/09 | 1,245 | 1,252 | 1,215 | 1,220 | -23 | -1.9% | 413,700 |
| 2021/09/08 | 1,300 | 1,316 | 1,221 | 1,243 | -72 | -5.5% | 1,064,400 |
| 2021/09/07 | 1,288 | 1,379 | 1,287 | 1,315 | +34 | +2.7% | 1,228,500 |
| 2021/09/06 | 1,275 | 1,288 | 1,267 | 1,281 | +5 | +0.4% | 231,100 |
| 2021/09/03 | 1,269 | 1,287 | 1,252 | 1,276 | +12 | +0.9% | 420,300 |
851～
900
件表示中 / 2464件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 240,900円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 科研薬 | 386,700円 | +30.5% | +111.0% | 4.91% | 10.90倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 261,300円 | +13.9% | +6.6% | 2.68% | 6.81倍 | 0.81倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 237,400円 | +21.7% | +999.9% | 0.00% | 9.89倍 | 3.27倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
